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Background
Neuroprotective treatment for the prevention of second-
ary injury to head injury still lacks clinical utility. In our
experimental study of controlled cortical impact (CCI) in
rats, we investigate, whether transplantation of GLP-1-
transfected stem cells encapsulated in alginate may pre-
vent cellular responses after trauma
Materials and methods
CCI was applied to 50 male adult Sprague-Dawley rats.
Trauma groups consisted of trauma only, animals treated
with GLP-1-transfected human mesenchymal stem cells
(GLP-1 hMSC) encapsulated in alginate beads, with non-
transfected encapsulated human mesenchymal stem cells
(hMSC) and sham-treated with alginate capsules only
(ALG). Seven healthy and untreated animals served as
age-matched controls. Alginate beads were stereotactically
implanted into the right lateral ventricle before CCI.14
days post-injury, GLP-1-concentrations in the CSF were
measured and brains were histologically and immunohis-
tochemically assessed using specific antibodies against
NeuN, GFAP, MAP2 and GLP-1.
Results
Anti-NeuN immunostaining showed a significant
decrease of vital neurons in the dentate gyrus in the
trauma animals as well as in the groups treated with non-
transfected hMSC and with alginate capsules only. Both,
GFAP and MAP2-immunohistochemistry, assessed in the
area of contusion, mirrored the Anti-NeuN results show-
ing less pronounced cellular reactive changes in the GLP-
1 treated animals. Stem cells in the intraventricular com-
partment seem vital as well as positive staining of the
GLP-1 peptide at the trauma site was observed.
Conclusion
Our immunohistological findings on treatment with GLP-
1-transfected human mesenchymal stem cells in rats
resulted in less histological sequels after controlled corti-
cal impact trauma. This may break into new concepts for
local neuroprotective therapy in traumatic brain injury as
well as for other neurodegenerative diseases of the central
nervous system, e.g. chronic hydrocephalus.
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